Abstract
Pathogenic Acinetobacter species, most notably Acinetobacter baumannii, are a significant cause of healthcare‐associated infections worldwide. Acinetobacter infections are of particular concern to global health due to the high rates of multidrug resistance and extensive drug resistance. Widespread genome sequencing and analysis has determined that bacterial antibiotic resistance is often acquired and disseminated through the movement of mobile genetic elements, including insertion sequences (IS), transposons, integrons, and conjugative plasmids. In Acinetobacter specifically, resistance to carbapenems and cephalosporins is highly correlated with IS, as many ISAba elements encode strong outwardly facing promoters that are required for sufficient expression of β‐lactamases to confer clinical resistance. Here, we review the role of mobile genetic elements in antibiotic resistance in Acinetobacter species through the framework of the mechanism of resistance acquisition and with a focus on experimentally validated mechanisms.
Keywords: Acinetobacter, antibiotic resistance, insertion sequence, mobile genetic element, transposon
Pathogenic Acinetobacter species are a significant cause of healthcare‐associated infections worldwide. Acinetobacter infections are of particular concern due to the high rates of multidrug resistance and extensive drug resistance. Bacterial antibiotic resistance is often acquired and disseminated through movement of mobile genetic elements including insertion sequences, transposons, integrons, and conjugative plasmids. We review the role of mobile genetic elements in antibiotic resistance in Acinetobacter species.

INTRODUCTION
Pathogenic Acinetobacter are a significant cause of opportunistic infections and represent a critical threat due to increasing antimicrobial resistance. 1 Antimicrobial‐resistant infections cause a significant global health burden and were estimated to contribute to 4.95 million deaths worldwide in 2019. 2 The World Health Organization predicts a global rate of 10 million deaths per year due to drug‐resistant bacterial infection by 2050 if no action is taken, emphasizing the critical importance of understanding multidrug‐resistant (MDR) pathogens. 3 Acinetobacter spp. demonstrate this threat through growing levels of MDR incidence, including resistance to many last‐resort antibiotics, such as colistin. 4 , 5
Within Acinetobacter spp., Acinetobacter baumannii presents the highest concern as a healthcare‐associated pathogen. 6 Carbapenem‐resistant isolates of A. baumannii have increased in number worldwide, 7 and the United States Center for Disease Control and Prevention labeled carbapenem‐resistant A. baumannii as a threat level “urgent” due to the difficulty in treatment. 8 A. baumannii can also cause community‐acquired infections, which are less likely to be MDR but often have severe clinical outcomes. 9 , 10 Antibiotic resistance in A. baumannii is due to intrinsic and acquired antibiotic‐resistance genes and is promoted in part by genomic plasticity and adaptation, including mobile genetic elements. 11 , 12
The global increase of MDR A. baumannii has been linked to the expansion of multiple clones, often referred to as “global clones.” 13 Most MDR strains have historically belonged to global clones I and II (GC1 and GC2) that were identified in the 1970s. 14 , 15 The emergence of antimicrobial resistance in GC1 corresponded with the acquisition of the AbaR resistance island, further modified in later sublineages. 16 , 17 , 18 More recently, researchers have identified infections by what were once uncommon global clones, such as III, VI, and VII, indicating the broad increase in clonal invasiveness. 19 , 20 There are currently nine defined global clones for A. baumannii that are often found to cocirculate in hospital settings, 21 but GC1 and GC2 remain the most common globally. 1 , 22 , 23 , 24 The GC type of community‐acquired strains is often not reported. One study found that a community‐acquired strain does not fall within either GC1 or GC2 lineages, but is most closely related to a GC2 isolate, 25 and another one found in community‐acquired pneumonia caused by a strain with multi‐locus sequence type ST77 (Pasteur), which does not belong to a GC. 26 This is consistent with findings that community and nosocomial strains are distinct, with nosocomial strains typically having increased drug resistance. 27 , 28 Subtypes of the global clones and their antibiotic resistances can be determined by multiple factors beyond the presence of the AbaR. Notably, Acinetobacter insertion sequences (IS) elements can activate and mobilize carbapenem‐hydrolyzing β‐lactamases, which represent the greatest public health threat in A. baumannii infections. 7 , 22 , 29 Many potential roles for mobile genetic elements in Acinetobacter antibiotic resistance have been identified by genomic sequencing and analyses that are too numerous to comprehensively discuss in this review. Here, we review the role of mobile genetic elements in antibiotic resistance in Acinetobacter organized by the mechanism of resistance acquisition with an emphasis on experimentally validated mechanisms.
IS elements are the simplest and smallest mobile genetic elements at roughly 1 kb, consisting of terminal inverted repeats usually flanking one or two open reading frames encoding a transposase enzyme (Figure 1A). The transposase is responsible for the excision and integration of the element into the genome and does so by recognizing and binding the terminal inverted repeats as reviewed previously. 30 , 31 Transposition can be replicative using a “cut and paste” mechanism. IS element transposition can be site‐specific or random and typically creates short (2–14 base pair) flanking direct repeats from the genomic insertion site, also known as transposition site duplication. IS elements are often named including the first three letters of the species in which they were discovered, thus A. baumannii IS elements are designated ISAba. In A. baumannii laboratory strains, such as AB5075 and 17978, IS elements are one source of genetic differences between closely related strains passaged in different laboratories or distributed by culture collections. 32 , 33 IS elements can contribute to genomic variability as well as create significant phenotypic changes for the bacterial host, both favorable and unfavorable.
FIGURE 1.

Overview of mobile genetic elements that contribute to Acinetobacter antibiotic resistance. (A) Insertion sequences (IS) are comprised of transposase genes flanked by inverted repeats; insertion into target DNA generates direct repeats (also known as transposition site duplications). (B) Transposons are similar to IS but can also carry cargo genes, including antibiotic‐resistance genes. (C) Composite transposons are generated when cargo genes are flanked by IS elements, which can be in multiple orientations. (D) Integrons encode the intI integrase gene and incorporate gene cassettes at att sites. (E) XerCD‐dif sites can include cargo genes flanked by XerC and XerD sites separated by small spacer sequences. In Acinetobacter, XerCD‐dif sites are often encoded on plasmids flanking antibiotic‐resistance genes. (F) Degraded elements, such as miniature inverted‐repeat transposable elements (MITE), retain inverted repeats but do not encode their own transposase enzymes. (G) Conjugative plasmids can carry cargo genes and mobile genetic elements and can be transferred between bacteria by the origin of transfer (oriT).
Transposons have a similar structure to IS elements but carry additional cargo genes, which can include antibiotic‐resistance genes (Figure 1B). Composite transposons are comprised of complete IS elements that act as terminal repeats, flanking the cargo genes of the transposon (Figure 1C). 34 Transposons mobilize similarly to IS elements, using transposase enzymes that recognize the terminal repeats of the element and insert site‐specifically or randomly. Specific transposon families and their role in antibiotic resistance have been reviewed in depth previously. 31
Integrons and site‐specific recombinases are genetic elements capable of acquiring resistance cassettes independently of one another (Figure 1D). 35 A gene cassette is a small nonautonomous mobile element typically associated with integrons and often encodes for antibiotic resistance. 36 Gene cassettes consist of one open reading frame without a promoter sequence and one recombination site called attC that is recognized by the IntI recombinase. The recombination site is critical for integration into an integron structure. Integrons are ubiquitous in bacterial genomes and exist as chromosomal integrons that are not typically involved in antibiotic resistance and mobile integrons that are associated with antibiotic resistance. 35 All integrons contain a conserved “platform” comprised of the intI encoding a tyrosine recombinase, an attI recombination site, and a Pc promoter. 37 The tyrosine recombinase is responsible for the integration of new genes at the attI recombination site near the Pc promoter, which drives the expression of the cargo genes. By themselves, the stable platforms are nonmobile. Integrons only become mobile by association with transposons as a compounded element. In this case, the cargo genes are often associated with antibiotic resistance and are a cause of MDR in multiple organisms. 38 , 39 , 40 There are five classes of integrons which have been reviewed in depth. 35 , 41 , 42 Class 1 integrons are the most clinically relevant and can also be associated with IS91‐like “common regions” to form ISCR which are capable of mobilization via transposition. 43 Additionally, XerCD‐dif is a site‐specific tyrosine recombinase system important for maintaining monomers of bacterial circular DNA (Figure 1E) 44 that has been posited to contribute to the dissemination of antibiotic resistance in Acinetobacter. 45
Miniature inverted‐repeat transposable elements (MITEs) are nonautonomous elements that are thought to be degraded from ancestral IS elements or transposons. MITEs retain inverted repeat structures but do not encode the cognate transposase enzyme (Figure 1F). 46 However, MITEs can be mobilized by transposases of other mobile genetic elements present in the genome. Complex MITE‐containing genetic structures can be difficult to identify de novo because they often do not contain open reading frames. Despite the difficulty in identification, degraded elements have been found to contribute to the growing problem of antibiotic resistance in Acinetobacter. 47 , 48
Conjugative plasmids are examples of extrachromosomal mobile genetic elements that can be transferred between bacteria and can also contain other nested elements (Figure 1G). 34 Conjugative plasmids are a major contributor to antibiotic‐resistance dissemination and can be transmitted vertically—from parent cell to progeny—or horizontally by conjugation. 34 Conjugative plasmids often carry cargo genes that encode antibiotic resistance directly or within other elements, such as IS elements or transposons. 49 Conjugative plasmids encode replication initiation sites, an origin of transfer (oriT), and typically encode the transfer genes required for mobilization from the donor cell to a recipient cell (Figure 1G). 50 Conjugative plasmids can be broad‐host‐range and replicate in a variety of bacterial hosts or narrow‐host‐range which are limited to closely related taxa. The transfer of conjugative plasmids is a growing concern in terms of antibiotic resistance. Due to the potential broad‐host‐range for transfer, antibiotic‐resistance genes can be exchanged across bacterial taxa, including pathogenic bacteria. This poses a great public health risk as treatment options for MDR and extensive drug resistance (XDR) pathogens are declining.
Compounded elements or “nesting doll” elements where one feature is embedded into another 51 complicate categorizing elements into one type. 52 , 53 Simple examples include IS elements, transposons, or integrons present on conjugative plasmids that allow horizontal gene transfer of multiple elements simultaneously. 54 , 55 , 56 Other well‐described elements include the presence of IS within large transposon structures, for example, in the Tn7 transposon family; however, Tn7 transposons are separate entities than composite transposons. 57 Compounded elements are often capable of mobilization and, therefore, contribute to antibiotic‐resistance dissemination.
Bacteriophage are an additional type of mobile genetic element that likely contribute to antibiotic‐resistance dissemination by horizontal gene transfer in Acinetobacter; however, we do not discuss their role in detail in this review. While mobile genetic elements differ in their characteristics, the mechanisms by which they contribute to antibiotic‐resistance acquisition and dissemination often overlap. Here, we review work identifying mobile genetic elements in the acquisition and dissemination of antibiotic resistance organized by the mechanism of resistance acquisition.
MOBILE GENETIC ELEMENTS CAN CONFER ANTIBIOTIC RESISTANCE BY ALTERING GENE EXPRESSION
Transposition of IS elements or transposons can promote antibiotic resistance by changing bacterial gene expression, such as by providing strong promoter sequences to downstream genes, disrupting promoters to decrease expression, or inactivating genes (Figure 2). Because these effects do not require the element to encode for an antibiotic‐resistance gene, simple elements, such as IS, can promote antibiotic resistance (summarized in Table 1).
FIGURE 2.

Mechanisms of antibiotic resistance by insertion sequence transposition. (A) Many ISAba elements encode strong outward promoters and promote antibiotic resistance by increasing the expression of genes, such as intrinsic antibiotic‐resistance genes. (B) IS elements can confer antibiotic resistance by downregulating competitive enzymes or regulators. (C) IS elements can confer antibiotic resistance by disrupting genes that encode porins, transporters, regulators, or antibiotic targets. Abbreviation: IS, insertion sequences.
TABLE 1.
Regulation of gene expression by mobile genetic elements that confer antibiotic resistance
| Species | Genetic element | Regulation mechanism | Antibiotic resistance | Reference |
|---|---|---|---|---|
| Acinetobacter baumannii | ISAba1 | Promoter sequence increased the expression of bla OXA‐23 | Carbapenem | 79, 95, 168 |
| Promoter sequence increased the expression of bla OXA‐51‐like and likely bla OXA‐23‐like | Carbapenem | 66 | ||
| Promoter sequence increased the expression of bla OXA‐69/OXA‐51 | Carbapenem | 66 | ||
| Promoter sequence increased the transcription of sul2 | Sulfonamide | 79, 86 | ||
| Promoter sequence increased the expression of ampC | Cephalosporin | 60, 61, 62, 63 | ||
| Promoter sequence increased the expression of eptA | Colistin | 5 | ||
| Increased expression of bla OXA‐51 | Carbapenem | 4, 67, 68 | ||
| Promoter sequence increased the expression of bla OXA‐66 of the bla OXA‐51 family | Carbapenem | 65 | ||
| Truncation and activation of adeS, which activates adeABC encoding an efflux pump | Tigecycline | 87 | ||
| Promoter sequence increased the expression of adeIJK |
Erythromycin Tetracycline Azithromycin |
88 | ||
| ISAba1, ISAba2, ISAba3‐like, IS18 | Promoter sequence for bla OXA‐58 | Carbapenem | 84 | |
| ISAba3/ISAba825 | Composite ISAba3/ISAba825 promoter sequence increased the expression of bla OXA‐58 | Carbapenem | 85 | |
| ISAba10 | Putative promoter sequence of bla OXA‐23 | Carbapenem | 95 | |
| ISAba11 | Insertion decreased the transcription of ispB, restoring antibiotic resistance to ∆mlaF strain |
Meropenem Imipenem Gentamicin |
91 | |
| ISAba13 | Insertion upstream decreased the transcription of adeN |
Erythromycin Tetracycline Azithromycin |
88 | |
| ISAba125 | Promoter sequence increased the expression of ampC | Cephalosporin | 64 | |
| Promoter sequence increased the expression of bla NDM‐1 | Carbapenem | 74, 75 | ||
| ISAba4 | Increased expression of bla OXA‐23 | Carbapenem | 81, 82 | |
| Acinetobacter bereziniae | IS18 | Promoter sequence for bla OXA‐257 | Carbapenem | 83 |
| ISAba1, ISAba2, ISAba3‐like, IS18 | Promoter sequence for bla OXA‐58 | Carbapenem | 84 | |
| Acinetobacter nosocomialis | ISAba1 | Increased expression of bla OXA‐51 | Carbapenem | 4, 67, 68 |
| Acinetobacter radioresistens | ISAcra1 | Promoter sequence increased the expression of bla OXA‐23 | Carbapenem | 77 |
IS elements can provide strong promoter sequences to express antibiotic‐resistance genes
IS elements are significant contributors to carbapenem‐resistant Acinetobacter by providing strong promoters to otherwise silent bla genes encoding β‐lactamase enzymes. A. baumannii intrinsically encodes two classes of β‐lactamases that do not confer clinical resistance at basal expression levels: (1) the chromosomally encoded ampC (also known as bla ADC) encodes a cephalosporin‐hydrolyzing β‐lactamase 58 and (2) bla OXA‐51 encodes a carbapenem‐hydrolyzing class D β‐lactamase OXA‐51 family. 59 However, insertion of an IS element upstream of ampC or bla OXA‐51 can provide a strong outward promoter and confer clinical resistance to cephalosporins or carbapenems, respectively. For example, ISAba1 has been identified to promote ampC expression and clinical cephalosporin resistance within composite transposons (IS elements are depicted in Figure 3). 60 , 61 , 62 , 63 ISAba125 inserted upstream of ampC also provides a strong promoter and confers cephalosporin resistance to the GC1 A. baumannii ACICU in a 9‐kb genomic island that appears to be acquired from the GC2 lineage by homologous recombination. 64 The dual role of IS elements as providing strong promoters and forming composite transposons is common in Acinetobacter genetic structures and is discussed in more detail below.
FIGURE 3.

Families and sizes of Acinetobacter IS elements. Each IS element mentioned is grouped by IS family: IS1 family, ISAba3; IS3 family, ISAba2; IS4 family, ISAba1; IS5 family, ISAba10, ISAba13, ISAba27; IS6 family, IS26; IS30 family, ISAba125, IS18; IS66 family, ISAba25; IS701 family, ISAba11; IS982 family, ISAba4, ISAba825; IS1595 family, ISAcra1. Variation in the number of transposase genes, IS length, and direct repeat length is depicted.
ISAba1 is similarly associated with promoting the expression of the intrinsic bla OXA‐51. One study isolated A. baumannii from a patient pre‐ and postantibiotic treatment, including imipenem; the pretreatment isolate was carbapenem sensitive, while the posttreatment isolate was carbapenem resistant. 65 Genetic analysis determined that the transposition of ISAba1 to upstream of the native bla OXA‐66 (bla OXA‐51 family) promoted expression of the carbapenemase, conferring clinical resistance. 65 Similarly, a reference library of A. baumannii clinical outbreak clones provided evidence that while most isolates had genes encoding the β‐lactamase OXA‐69/OXA‐51, only isolates with ISAba1 upstream of bla OXA‐69/OXA‐51 produced enough enzyme to be carbapenem resistant. 66 Other studies of clinical isolate collections from Taiwan, Spain, and China have similarly shown that ISAba1 insertion upstream of bla OXA‐51 was associated with significantly increased expression and carbapenem resistance. 4 , 67 , 68 Together, these findings demonstrate that IS‐mediated enhancement of intrinsic β‐lactamase genes is an important mechanism by which A. baumannii acquires clinical resistance to carbapenems and cephalosporins.
Carbapenem resistance conferred by the production of the New Delhi metallo‐β‐lactamase 1 (NDM‐1) is also thought to require IS‐mediated activation of bla NDM‐1. bla NDM‐1 is not intrinsic to all A. baumannii strains, but is thought to have originated in A. baumannii as a chimera. 69 bla NDM‐1 was identified in 2008 and is now globally disseminated in Acinetobacter and Enterobacteriaceae. 56 , 70 , 71 bla NDM‐1 is thus far universally encoded downstream of an intact or truncated ISAba125, 72 , 73 which provides a ‐35 promoter region to promote bla NDM‐1 expression. 74 , 75 bla NDM‐1 is often encoded within a composite transposon Tn125, which includes ISAba125 and is further discussed below.
Similarly, the carbapenem‐hydrolyzing class D β‐lactamase (CHDL) OXA‐23 is thought to have originated in Acinetobacter radioresistens and is a significant contributor to carbapenem resistance in A. baumannii only when activated by adjacent IS elements. 76 Indeed, one study found that transposition of the native IS element ISAcra1 to upstream of bla OXA‐23 provides carbapenem resistance in A. radioresistens clinical isolates. 77 A. radioresistens is not typically found to cause infection; the fourth identified case of infection was documented in 2019. 78 Therefore, these data show that typically nonpathogenic bacteria can contribute to antibiotic resistance and dissemination through mobile genetic elements. ISAba1 is often found upstream of bla OXA‐23, providing a strong promoter and conferring carbapenem resistance in many clinical isolates. This was first demonstrated in A. baumannii strain RAM isolated from Cape Town, South Africa, where ISAba1 was shown to provide an extended ‐10 promoter sequence similar to sequences recognized by stress‐responsive σS of Escherichia coli RNA polymerase. 79 However, the implications of this similarity are unclear as A. baumannii does not encode an σS homolog. Numerous studies since have identified a relationship between ISAba1 insertion upstream of bla OXA‐23 and carbapenem resistance, and IS insertion is often part of a composite transposon structure as previously reviewed 80 and discussed below. ISAba4 has also been reported to activate bla OXA‐23 expression in isolates from Algeria and France 81 and was similarly found adjacent to bla OXA‐23 in an isolate from Egypt. 82 Together, these studies suggest that IS‐mediated enhancement of expression is required for bla OXA‐23 to confer carbapenem resistance.
IS elements are also associated with promoting the expression of acquired β‐lactamases. In a carbapenem‐resistant Acinetobacter bereziniae clinical bronchial secretion isolate, IS element IS18 provided a strong promoter sequence to a novel β‐lactamase gene, bla OXA‐257. 83 A. bereziniae is pathogenic but rarely antibiotic resistant, suggesting that the IS element was key to conferring carbapenem resistance. Similarly, in a survey of carbapenem‐resistant A. baumannii isolates containing the acquired β‐lactamase OXA‐58, bla OXA‐58 was typically located downstream of promoters introduced by IS elements, such as ISAba1, ISAba2, an ISAba3‐like element, and IS18. 84
When kanamycin‐tagged ISAba825 was experimentally introduced to A. baumannii, one group found that ISAba825 transposed and truncated a pre‐existing ISAba3 sequence. 85 Upon further examination, the two IS elements generated a composite promoter sequence where the −10 region was within ISAba3 and −35 within ISAba825 upstream of a bla OXA‐58 gene, conferring carbapenem resistance to the strain. 85 These studies are consistent with the model that the presence of bla genes is often not sufficient to confer clinical carbapenem or cephalosporin resistance and that a strong promoter provided by an IS element or other transposable element is often required for clinical resistance.
While IS element transposition is strongly associated with clinical β‐lactam resistance, IS element provision of strong promoters has also been found to increase resistance to other classes of antibiotics. In addition to increasing bla OXA‐23 expression in A. baumannii strain RAM, ISAba1 was also inserted upstream of the sulfonamide resistance gene sul2 and has been shown to increase transcription. 79 , 86 In another example, an ISAba1 insertion truncated and activated the expression of adeS, part of a two‐component system that activates the production of the AdeABC efflux pump and conferred tigecycline resistance. 87 An independent study found an ISAba1‐encoded promoter driving transcription of adeIJK, increasing ABUW5075 resistance to erythromycin and tetracycline when supplemented with host‐derived fatty acids in vitro. 88 Similarly, ISAba1 transposition upstream of the novel gene eptA in A. baumannii increased its expression and resulted in resistance to the polymyxin colistin. 5 eptA encodes a phosphoethanolamine transferase and is a homolog to pmrC which is also known to be associated with polymyxin resistance when overexpressed. 5 , 89 This poses a threat as colistin is currently a last resort treatment for MDR A. baumannii. 90 Together, these studies show that IS element transposition can provide strong promoter sequences to diverse antibiotic‐resistance genes, therefore, promoting MDR.
Downregulation of gene expression by IS element insertion can promote antibiotic resistance
IS elements have also been shown to confer antibiotic resistance by downregulation of gene expression (Figure 2B). For example, we previously isolated a suppressor mutant during a mouse model of A. baumannii lung infection in which antibiotic resistance was restored to an mlaF mutant strain. 91 This suppressor mutation was identified as an ISAba11 transposition to the 5’ untranslated region of ispB, an essential isoprenoid biosynthesis gene. 91 This suppressor mutation reduced the expression of ispB and restored resistance to multiple antibiotics, including meropenem, imipenem, and gentamicin. 91 The exact mechanism of restoring antibiotic resistance in this strain is unknown and may be related to competition for a shared metabolite used by IspB and undecaprenyl pyrophosphate synthase (UppS), which is required for cell envelope biogenesis. An in vitro study selective for erythromycin‐resistant ABUW5075 in the presence of host fatty acids identified an ISAba13 transposition upstream of the transcriptional regulator adeN, resulting in a 13.4‐fold decrease in transcription. 88 In this study, the presence of host fatty acids promoted the development of mutations cross‐resistant to tetracycline and azithromycin. These examples show the variety of mechanisms by which mobile genetic elements can promote resistance phenotypes through disruption or downregulation of a gene. Additionally, these studies highlight the idea that mobile genetic element‐mediated mutations selected in the host environment may confer enhanced resistance to antibiotics.
IS element disruption of bacterial genes to confer antibiotic resistance
IS are also found to confer antibiotic resistance by disrupting genes (Figure 2C). A recent analysis of nine pathogens found that mobile genetic element‐mediated gene disruption is an important contributor to antibiotic resistance in clinical isolates. 92 One common mechanism of IS element transposition conferring antibiotic resistance is by disrupting membrane or secretory proteins required for antibiotics to enter the cell. Disruptions in porins have been shown to cause broad resistance to antimicrobials due to their nonspecific and passive diffusion properties. 93 Multiple analyses of A. baumannii carbapenem‐resistant clinical isolates revealed insertions disrupting the outer membrane protein gene carO by ISAba825, ISAba125, ISAba10, and ISAba27 (Table 2). 94 , 95 , 96
TABLE 2.
Genetic disruptions that confer antibiotic resistance in Acinetobacter
| Species | Genetic element | Gene(s) disrupted | Antibiotic resistance | Reference |
|---|---|---|---|---|
| Acinetobacter baumannii | ISAba1 | Hypothetical genes | Mecillinam or imipenem (in ∆bfmRS strain) | 102 |
| adeS | Tigecycline | 99 | ||
| adeN | Tigecycline | 99 | ||
| ISAba10 | carO | Carbapenem | 95 | |
| ISAba11 | lpxA, lpxC | Colistin | 100 | |
| cspC, ACX60_RS05385 (predicted NUDIX hydrolase), mnmA, prmB, ctpA, tusE, hypothetical genes | Mecillinam or imipenem (in ∆bfmRS strain) | 102 | ||
| adeN | Ciprofloxacin | 97 | ||
| ISAba27 | carO | Carbapenem | 96 | |
| adeN | Tigecycline | 99 | ||
| ISAba125 | carO | Carbapenem | 94 | |
| lpxA | Polymixin B | 101 | ||
| adeN | Tigecycline | 99 | ||
| ISAba825 | carO | Carbapenem | 94 |
Disruption of transcriptional regulators or antibiotic targets is another mechanism by which the transposition of IS can promote antibiotic resistance. In experimental evolution selecting for ciprofloxacin resistance in A. baumannii 17978, strains were isolated in which IS701‐family ISAba11 transposition disrupted adeN. 97 AdeN is a repressor of the genes that encode the efflux pump AdeIJK that promote resistance to multiple antimicrobials. 98 Disruption of the Ade efflux pump system can be found in clinical isolates as well. One study found four independent isolates with IS element disruptions in adeN or adeS, which conferred tigecycline resistance. 99 Two of the isolates, ISAba1 inserted in adeS at two different sites, indicated independent transposition events. 99 In other isolates, adeN was disrupted by ISAba1, ISAba125, and ISAba27 conferring tigecycline resistance. 99 Disruption of adeN was associated with a 35‐fold and 45‐fold increase in adeB expression, while disruption of adeS was associated with a two‐fold and six‐fold increase in adeJ expression. 99 As an example of disruption of an antibiotic target, an experimental selection for resistance to the last‐resort, polymyxin antibiotic (colistin) identified ISAba11 inactivation of lipid A biosynthesis genes lpxA and lpxC, which led to a loss of the colistin target lipooligosaccharide in A. baumannii 19606. 100 Similarly, when an A. baumannii clinical isolate was selected for resistance to polymyxin B in vitro, ISAba125 was found to disrupt lpxA in the resulting polymyxin B‐resistant isolate. 101
Finally, disruption of other processes can promote antibiotic resistance by unknown mechanisms. For example, a suppressor screen for mutations that restore antibiotic resistance to a ∆bfmRS mutant in A. baumannii 17978 identified numerous IS element disruptions, including ISAba11 insertions in the cold shock protein gene cspC, a predicted NUDIX hydrolase gene, the tRNA gene mnmA, prmB ribosomal protein, ctpA peptidase, two independent insertions in the tusE sulfite reductase gene, and multiple ISAba11 and ISAba1 insertions in hypothetical genes. 102 These studies show that IS‐mediated gene‐disruption can promote antibiotic resistance in both clinical and experimental settings.
MOBILE GENETIC ELEMENTS CARRYING GENES THAT CONFER ANTIBIOTIC RESISTANCE
Many mobile genetic elements contain genes that directly encode for antibiotic resistance, including carbapenems, tetracyclines, macrolides, and aminoglycosides (summarized in Table 3). Resistance genes may be located on the bacterial chromosome or on a plasmid and can be trapped by transposons or other elements and subsequently mobilized into new genomic sites or recipient bacteria.
TABLE 3.
Selected transposons and integrons that carry antibiotic resistance genes
| Species | Genetic element | Resistance gene | Abx resistance | Reference |
|---|---|---|---|---|
| Acinetobacter NFM2 (prawn isolate) | Tn402‐like class 1 integron‐MITE structure | sul | Sulfonamide | 154 |
| Acinetobacter spp. | IN86 with MITE sequences |
bla IMP‐1 acc(6’)‐31 addA1 |
Aminoglycoside | 155 |
| Acinetobacter baumannii | Tn2006 (ISAba1 flanks) | bla OXA‐23 | Carbapenem | 81 |
| Tn2007 (ISAba4 flank) | bla OXA‐23 | Carbapenem | 81 | |
| Tn2008 (ISAba1 flank) | bla OXA‐23 | Carbapenem | 104 | |
| Tn2008B (ISAba1 flank) | bla OXA‐23 | Carbapenem | 105 | |
| Tn2009 (ISAba1 flanks) | bla OXA‐23 | Carbapenem | 106 | |
| Tn6924 |
bla NDM aph46 |
Carbapenem Amikacin |
103 | |
| Tn6020 | aphA1 | Tobramycin | 126, 127 | |
| Tn6080 | ISAba1‐bla OXA‐51 | Carbapenem | 115, 116 | |
| Tn6168 | ampC | Cephalosporins | 60 | |
| Tn6250 (ISAba1 flanks) |
strA srtB sul2 |
Streptomycin Sulphonamide |
125 | |
| Tn6252 (ISAba1 flanks) | blaOXA‐236 | Carbapenem | 125 | |
| Tn125 (ISAba125 flanks) | bla NDM‐1 | Carbapenem | 118, 119, 120, 121 | |
| TnaphA6 (ISAba125 flanks) | aphA6 | Aminoglycoside | 122, 123 | |
| ISCR1 | bla NDM‐1 | Carbapenem | 138 | |
| ISCR2 | sul2 | Sulfonamide | 137 | |
| ISCR27 | bla NDM‐1 | Carbapenem | 43 | |
|
intI1 intI2 intI3 |
aac(3)‐Ia dfrA15 aac(6')‐Ib dfrA17 dfrA7 aadA5 |
Multiple | 169 | |
| Tn402‐like class 1 integron‐MITE structure |
sul bla IMP‐5 |
Sulfonamide Carbapenem |
47 | |
| XerCD‐dif, ISAba825, TnaphA6 |
bla OXA‐58 aphA6 |
Carbapenem Aminoglycoside |
151 | |
| XerCD‐dif | bla OXA‐24 | Carbapenem | 144, 145, 146 | |
| XerCD‐dif | bla OXA‐72 | Carbapenem | 124, 150 | |
| XerCD‐dif |
Tet39 msrE mphE |
Tetracycline Macrolide |
152 | |
| Class 1 integron bound by IS26 |
aadB aadA2 |
Tobramycin Streoptomycin/Spectinomycin |
136 | |
| p1AB5075 integron‐like structure | aadB | Tobramycin | 139 | |
| Acinetobacter bereziniae | Class 1 integron‐MITE structure |
aacA7 bla VIM‐2 accC1 |
Aminoglycoside Carbapenem |
48 |
| Acinetobacter pittii | Class 1 integron | bla IMP‐1 | Imipenem | 135 |
| XerCD‐dif | bla OXA‐72 | Carbapenem | 135, 148, 149 | |
| XerCD‐dif | bla OXA‐207 | Carbapenem | 147 | |
| Acinetobacter johnsonii | Class 1 integron‐MITE structure containing an ISCR1 region | bla PER‐1 | Carbapenem | 48 |
| Tn6681 containing degraded ISAba1 elements and intact ISAba14 elements in pFM‐M19 plasmid | bla OXA‐23 | Carbapenem | 109 |
Antibiotic‐resistance genes as transposon cargo
Antibiotic‐resistance genes often serve as cargo genes for transposons. Antibiotic exposure may positively select for transposons that carry resistance genes, contributing to the maintenance of the transposon in the genome. The growing rate of A. baumannii carbapenem resistance is thought to be mostly caused by the spread of two European clones that carry bla genes. 15 However, one study isolated a new clone carrying a novel transposon, Tn6924, that contained the cargo genes bla NDM, a metallo‐β‐lactamase conferring carbapenem resistance, and multiple copies of aph46, an amikacin resistance gene. 103 As discussed in the following sections, most transposons found to carry antibiotic‐resistance genes in Acinetobacter are composite transposons generated by ISAba elements. These composite transposons are thought to contribute to the intermolecular spread of antibiotic‐resistance genes, including mobilization between the genome and conjugative plasmids.
Composite transposons and IS aid in the mobilization of antibiotic‐resistance genes
As discussed above, IS activation of β‐lactamase gene expression is a major contributor to carbapenem resistance in Acinetobacter. These bla genes are sometimes carried in composite transposons comprised of flanking IS elements that can also activate the expression of the bla gene. Bla OXA‐23 is an important carbapenem‐resistance determinant that is typically carried in one of five transposon structures: Tn2006, Tn2007, Tn2008, Tn2008B, and Tn2009 (reviewed by Nigro and Hall, 2016). 80 , 81 , 104 , 105 , 106 Of these, Tn2006 and Tn2009 are composite transposons and only Tn2006 has been experimentally confirmed to be capable of transposition. 107 However, while Tn2008 and Tn2008B only have a single copy of ISAba1, their ISAba1‐bla OXA‐23 units have been observed in multiple locations in the genome with a characteristic 9‐basepair direct repeat, suggesting that they are capable of transposing and, therefore, leading to their designation as transposons. 105 , 108 Similarly, Tn2007 has a single copy of ISAba4 associated with bla OXA‐23 and flanked by direct repeats, suggesting that it transposed at some point. 81 Recently, A. johnsonii M19 was found to carry the bla OXA‐23 gene in the composite transposon Tn6681 which contained degraded ISAba1 elements and intact ISAba14 elements in the conjugative plasmid pFM‐M19, which could be conjugated to E. coli. 109 However, the role of IS element promoters in conferring carbapenem resistance and the ability of the Tn6681 transposon to mobilize have not been explored.
The prevalence of each transposon structure appears to vary by location. In two independent collections of isolates in China, only Tn2008 was identified as carrying bla OXA‐23. 110 , 111 However, another study in China showed that the majority of bla OXA‐23 was found within Tn2006, 112 suggesting that there can be significant variability within a geographic region. In a concerning finding, sequencing of A. baumannii isolates from Egypt identified the presence of bla OXA‐23 in these composite transposon structures, one of which was inserted in the prophage phiOXA‐A35 in 6/54 strains. 82 PhiOXA‐A35 is identical to a prophage in A. baumannii ABUW‐5075 113 that was originally isolated in the United States, 114 demonstrating that the prophage has been found in multiple geographic areas. Mitomycin C was used to induce phage, and purified phage particles were isolated carrying bla OXA‐23 as determined by PCR, 82 suggesting the potential for phage‐mediated spread of bla OXA‐23.
Similar transposon structures have been identified carrying other antibiotic‐resistance genes. The ISAba1‐bla OXA‐51 complex has also been found on plasmids in Acinetobacter spp., suggesting that it is capable of transposition and thus has been named Tn6080. 115 , 116 Cephalosporin‐resistant A. baumannii isolates from Australia and the United States contained the composite transposon Tn6168 which has flanking ISAba1, one of which activates a copy of the β‐lactamase gene ampC. 60 ISAba1 has been shown to promote ampC transcription as discussed above. 61 , 62 , 63 , 117 bla NDM‐1 has been found flanked by ISAba125 to generate Tn125 in a number of isolates. 118 , 119 , 120 , 121 Krahn et al. also demonstrated the transfer of Tn125 to a susceptible strain, but it was likely due to phage transduction rather than transposon‐mediated mobilization. 120 Another study found bla OXA‐58 flanked by an ISAba3‐like element, suggesting that it may have been mobilized within a composite transposon structure. 84 TnaphA6 has ISAba125 flanks and carries the aphA6 gene that confers resistance to aminoglycosides; 122 , 123 a circular form of TnaphA6 has been identified, suggesting that it could contribute to interbacterial aminoglycoside resistance spread. 124 A clinical isolate, LAC‐4, was studied due to its status of MDR and two novel composite transposons, Tn6250 and Tn6252, encoding genes for streptomycin and sulphonamide resistance and carbapenem resistance, respectively. 125 LAC‐4 also encoded an additional genomic island 3 (GI3) flanked by novel IS element ISAba25 that contained an RND‐type efflux pump system AdeIJK hypothesized to contribute to broad antibiotic resistance. 125 Many other genomics studies have identified similar structures, which are too numerous to comprehensively cover here.
In one notable example, transposition and amplification led to the within‐patient evolution of tobramycin resistance. Serial samples collected from the same patient identified multiple instances of amplification of Tn6020, which encodes aphA1 flanked by direct repeat copies of IS26. 126 , 127 One isolate had a 15.2‐kb region and led to ∼6X amplification; however, in another isolate, the duplication relied on the replicative transposition of Tn6020, which then allowed amplification of ∼65X. 127 Subsequent long‐read sequencing analysis determined that the amplification likely occurred via a circular translocatable unit. 128 Similar mechanisms could be selected for in vitro in other A. baumannii strains 127 and have been observed for a plasmid‐based replicon in which bla OXA‐58 flanked by ISAba2, ISAba3, and IS26 was amplified and conferred carbapenem resistance. 129 , 130 Tandem duplication of antibiotic‐resistance genes flanked by IS elements has been observed in other organisms leading to antibiotic heteroresistance, in which a subpopulation of bacteria are antibiotic resistant and can lead to treatment failure (as previously reviewed). 131 Therefore, the mechanism of transposition and gene amplification has potentially broad clinical implications. A study in Acinetobacter baylyi found that IS1236‐mediated gene amplification events were inconsistent with homologous recombination, suggesting that these amplifications may utilize illegitimate recombination, perhaps from transposase‐mediated DNA cleavage. 132 While this A. baylyi study investigated a different IS element, it provides insight into potential genetic mechanisms by which tandem duplication and amplification may lead to clinical antibiotic resistance in pathogenic Acinetobacter. Together, these examples suggest that composite transposons generated from IS element flanks are important mediators of antibiotic‐resistance gene mobilization in Acinetobacter.
Class 1 integrons can promote antibiotic resistance by the acquisition of antibiotic‐resistance genes
Integrons are site‐specific recombination systems that can incorporate arrays of foreign genes into a bacterial genome, including antibiotic‐resistance cassettes. Acinetobacter species often carry integrons associated with antibiotic resistance. 133 An early 2002 survey of integrons in clonally divergent Italian A. baumannii isolates identified identical class 1 integron structures encoding resistance to multiple antibiotics suggesting transfer of class 1 integrons between strains. 134 In another example, in a large collection of Acinetobacter nosocomialis and Acinetobacter pittii isolates from Taiwan, two A. pittii isolates had plasmids encoding class 1 integrons carrying the imipenemase‐encoding bla IMP‐1. 135 Similarly, an IS26‐bound class 1 integron resistance island carrying aadB (tobramycin resistance) and aadA2 (streptomycin/spectinomycin resistance) was recently identified in a new genomic locus and named AbGRI4. 136 Many A. baumannii integrons are encoded in association with IS91‐like “common regions” (ISCR) that form transposable units. 43 For example, A. baumannii strains carry ISCR2 with sul2 that confers sulfonamide resistance. 137 Some A. baumannii strains carry the ISCR3 family member ISCR27, which may have mobilized the bla NDM‐1 progenitor to A. baumannii, 69 while ISCR1 may have contributed to the subsequent mobilization of carbapenem resistance by bla NDM‐1. 138 These examples show that class 1 integrons can be important platforms for assimilation of antibiotic‐resistance genes and contribute to antibiotic‐resistance dissemination by transposition when they are part of ISCR families.
A 2020 study showed that duplication of a plasmid‐encoded composite class 1 integron controls virulence switching in A. baumannii AB5075. 139 Prior to this study, A. baumannii AB5075 and many other recent clinical isolates were known to have a biphasic virulent/opaque (VIR‐O) or avirulent/transparent (AV‐T) colony phenotype in which VIR‐O colonies are also more resistant to hospital disinfectant and host stresses. 140 , 141 , 142 Anderson et al. showed that a third class, a low‐switching opaque variant, is controlled by the copy number of antibiotic resistance carrying composite integron on the plasmid p1AB5075, likely due to expression levels of a small RNA encoded within the aadB tobramycin‐resistance gene. 139 Duplication of the composite integron also increases resistance to antibiotics, such as tobramycin, 143 suggesting that there may be a tradeoff between antibiotic resistance and the virulent/opaque phenotype.
XerCD‐dif sites in Acinetobacter plasmids are associated with antibiotic‐resistance acquisition
The site‐specific recombination system XerCD‐dif (also known as pdif sites when encoded in plasmids) is thought to similarly integrate arrays of foreign genes. XerCD‐dif systems are present in most microorganisms with circular chromosomes and plasmids, and they resolve dimers generated through homologous recombination. 44 dif sites are typically encoded near the terminus of the chromosome and include short sequences recognized by XerC and XerD, separated by a 6–11 bp spacer. 44 In Acinetobacter, XerCD‐dif sites often flank antibiotic‐resistance genes on plasmids and are, therefore, associated with antibiotic‐resistance acquisition (reviewed in Balalovski and Grainge 2020). 45 bla OXA‐24 was the first resistance determinant found in XerCD‐dif sites in multiple plasmids. 144 , 145 , 146 Similarly, a bla OXA‐24 variant, bla OXA‐207, that has reduced catalytic efficiency but increased oxacillinase activity, was found flanked by XerCD‐dif in a carbapenem‐resistant A. pittii isolate in Spain. 147 bla OXA‐72 is also commonly found flanked by XerC and XerD sites in A. pitti 135 , 148 , 149 and A. baumannii. 124 , 150 In one study, multiple nonself‐transferrable plasmids carrying XerCD‐dif were found in A. baumannii AB242, one of which carried ISAba825‐bla OXA‐58 and a TnaphA6 transposon; these plasmids could be electroporated into A. nosocomialis where they were observed to carry out intramolecular rearrangements at the XerCD sites. 151 XerCD‐dif sites flanking tet39 tetracycline‐resistance gene and msrE and mphE macrolide‐resistance genes have also been identified, suggesting a role for XerCD‐dif system in integrating these resistance determinants. 152 A. baumannii XerCD have been shown to be functional proteins, 153 emphasizing their likely role in integrating new antibiotic‐resistance genes. However, the exact mechanisms by which XerCD‐dif sites integrate antibiotic‐resistance genes and contribute to their dissemination in Acinetobacter remain to be fully elucidated.
MITEs appear to contribute to the mobilization of class 1 integrons carrying antibiotic‐resistance genes
Multiple integron structures have been found flanked by MITEs in Acinetobacter spp. For example, the Acinetobacter strain NFM2 (related to Acinetobacter johnsonii) was isolated from an ocean prawn in Australia and found to encode an MDR cassette within a Tn402‐like class 1 integron flanked by 439‐bp MITEs. 154 A. johnsonii isolated from hospital sewage in China was found to contain the identical class 1 integron‐MITE structure in the same genomic location, but also incorporating an ISCR1 region and carrying a different antibiotic‐resistance gene, specifically a β‐lactamase gene bla PER‐1. 48 Interestingly, A. baumannii strain 65FFC was found to encode an IMP‐5 β‐lactamase within an identical class 1 integron‐MITE structure, but in a different genomic context. 47 Similarly, A. bereziniae strain 118FFC has a class 1 integron with aacA7‐bla VIM‐2‐aacC1 but in the genomic context of disrupting an IS26 tnpA gene. 48 Portions of the MITE sequences were also found in Acinetobacter clinical isolates from soft tissue and bloodstream infections that carried a class 1 integron, In86, carrying bla IMP‐1, aac(6′)‐31, and aadA1. 155 Acinetobacter class 1 integron‐MITE has not been experimentally demonstrated to be capable of transposition, but a similar structure in Enterobacter cloacae has been demonstrated to transpose. 156 Together, these findings suggest that the Tn402‐like class 1 integron‐MITE structure can incorporate different antibiotic‐resistance cassettes and transpose within the Acinetobacter genus.
CONJUGATIVE MOBILE GENETIC ELEMENTS AND THE INTERBACTERIAL SPREAD OF ANTIBIOTIC‐RESISTANCE GENES
Conjugative mobile genetic elements are a major mechanism by which antibiotic‐resistance genes are spread horizontally between strains and species. There are many examples of antibiotic resistance spread by conjugative mobile genetic elements that have been previously reviewed, 157 , 158 and, therefore, we will only briefly cover a few recent examples here (summarized in Table 3).
Conjugative plasmids aid in the dissemination of antibiotic‐resistance genes
Conjugative plasmids are thought to be a large contributor to the interbacterial spread of antimicrobial resistance genes in Acinetobacter. For example, XDR A. baumannii were shown to be capable of transferring kanamycin resistance to susceptible environmental Acinetobacter strains on the GR6 conjugative plasmid. 159 Interestingly, a 2020 survey of A. baumannii plasmids found that only 35% of plasmids carried antibiotic resistance and that gene flux between plasmids was primarily associated with IS elements and transposons. 160 Nested elements, such as plasmids carrying IS elements and transposons, may, therefore, be significant contributors to the intermolecular spread of antibiotic‐resistance genes. For example, the carbapenem‐resistant isolate A. baumannii A85 carries a bla OXA‐23 gene on a conjugative plasmid within the AbaR4 transposon, which is a composite structure of the Tn2006 structure (which has flanking ISAba1 elements) inserted in Tn6022; this conjugative plasmid was shown experimentally to be capable of transferring carbapenem resistance to susceptible strains. 161 Similarly, Tn2006 has been observed to be colocalized with TnaphA6 in a large conjugative plasmid in A. baumannii isolate D46. 162 More recently, the transposon Tn6681 was found encoded on the pFM‐M19 plasmid, which was demonstrated to be capable of conjugation and conferring carbapenem resistance to E. coli demonstrating intergenus transfer. 109 In a study of Bolivian A. baumannii hospital isolates, each was found to contain antibiotic‐resistance genes on plasmids, both with and without additional mobile genetic elements. 163 The spread of antibiotic‐resistance genes between isolates and species suggests that new modes of surveillance may be required to track these plasmid‐based outbreaks.
Conjugative plasmids and fitness tradeoffs
In addition to carrying antibiotic‐resistance genes, conjugative plasmids have been shown to encode strategies to balance antibiotic resistance and interbacterial competition. Weber et al. found that some MDR isolates of A. baumannii contain a conjugative plasmid that encodes negative regulators of the type VI secretion system (T6SS) as well as antibiotic‐resistance genes. 164 Within this population, some bacteria undergo spontaneous loss of the large conjugative plasmid which then allows for the T6SS‐mediated killing of competing bacteria but the loss of antibiotic resistance. 164 Others maintain the plasmid that confers resistance and represses the T6SS, therefore, creating a tradeoff between bacterial warfare and antibiotic resistance. 164 Another study showed that these conjugative plasmids must suppress their own T6SS in order to allow for successful conjugation to other cells due to requiring close cell–cell proximity. 165 These studies demonstrate the multifaceted effects of conjugative plasmids and the tradeoff between bacterial competition and antibiotic resistance.
To protect against spontaneous plasmid loss, some strains have integrated plasmid DNA into their chromosomes to preserve resistance genes. In isolates of Acinetobacter calcoaceticus subspecies anitratus, the plasmid RP4 codes for resistance to multiple antibiotics. 166 However, the RP4 plasmid cannot be maintained stably in the host, making integration of RP4 plasmid DNA into the host genome necessary to introduce a stable antibiotic‐resistance gene. 166 Therefore, while conjugative plasmids may encode many resistance genes and systems used to defend the host cell, competition and spontaneous plasmid loss pose fitness tradeoffs and challenges for bacteria.
Conjugative transposons facilitate the dissemination of antibiotic resistance
In addition to large conjugative plasmids, some families of transposons are capable of conjugation independent of plasmids. In some cases, these transposons are capable of conjugation but require other host factors to do so. Nonautonomous conjugative transposons rely on a bacterial protein RecA or RecO to form the circular intermediate required for receiving a transfer. 52 One study found that Acinetobacter baylyi required RecA to receive exogenous circular DNA in the form of transposon Tn1, 167 indicating that host bacterial factors may be required to confer antibiotic resistance offered by some transposons. These studies demonstrate the potential of conjugative transposons to contribute to the ongoing health crisis of antibiotic‐resistance dissemination.
CONCLUSIONS
Over the past few decades, rates of infection by MDR Acinetobacter have continued to increase. Infections by antibiotic‐resistant bacteria pose a grave threat to human health due to the lack of available treatment options. Therefore, it is critical to understand not only the molecular mechanisms of antibiotic resistance but also how bacteria use natural genetic plasticity to acquire and disseminate resistance. The genomic characterization of Acinetobacter clinical isolates has led to important discoveries linking antibiotic resistance to mobile genetic elements. Mobile genetic elements can promote high levels of genetic diversity, bacterial fitness, and antibiotic resistance to environmental strains and human pathogens alike. While mobile genetic elements commonly confer antibiotic resistance by encoding resistance genes, they can also alter the expression of native bacterial genes to promote antibiotic resistance. In Acinetobacter specifically, IS elements play a major role in promoting carbapenem resistance by providing strong promoters to β‐lactamase genes.
Additional work to characterize the molecular features of IS element transposition, integron function, and the mechanisms of XerCD‐dif sites in Acinetobacter plasmids may shed light on how these elements contribute to the evolution of antibiotic resistance in Acinetobacter. The use of techniques, such as long‐read sequencing, will also aid in the identification of tandem duplications of mobile elements. Long term, understanding the molecular mechanisms of how mobile genetic elements promote antibiotic resistance in Acinetobacter may lead to the development of improved surveillance and treatment. IS element transposition has been shown to lead to antibiotic‐resistance evolution within patients receiving treatment; 65 , 127 therefore, a better understanding of these mechanisms may also lead to the development of therapeutics to prevent resistance development during the course of antibiotic treatment. For example, understanding the genetic and biochemical mechanisms leading to gene amplification and antibiotic heteroresistance may help identify pathways to target this important clinical problem. In summary, mobile genetic elements contribute to antibiotic‐resistance acquisition and dissemination by multiple mechanisms in Acinetobacter species. A better understanding of the molecular features controlling mobile genetic element‐mediated antibiotic resistance in Acinetobacter may lead to improved surveillance and treatment of this important public health threat.
AUTHOR CONTRIBUTIONS
H.R.N. and L.D.P. conceptualized the review. All authors drafted and edited the manuscript. J.R.P. generated tables. H.R.N. and L.D.P. generated the figures.
COMPETING INTERESTS
The authors have no competing interests to declare.
PEER REVIEW
The peer review history for this article is available at https://publons.com/publon/10.1111/nyas.14918.
ACKNOWLEDGMENTS
L.D.P. is supported by the National Institute of Health (NIH) R00HL143441. We thank Dziedzom Bansah and Xiaomei Ren for the critical reading of the manuscript.
Noel, H. R. , Petrey, J. R. , & Palmer, L. D. (2022). Mobile genetic elements in Acinetobacter antibiotic‐resistance acquisition and dissemination. Ann NY Acad Sci., 1518, 166–182. 10.1111/nyas.14918
REFERENCES
- 1. Wenzler, E. , Goff, D. A. , Humphries, R. , & Goldstein, E. J. C. (2017). Anticipating the unpredictable: A review of antimicrobial stewardship and Acinetobacter infections. Infectious Diseases and Therapy, 6, 149–172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Murray, C. J. , Ikuta, K. S. , Sharara, F. , Swetschinski, L. , Aguilar, G. R. , Gray, A. , Han, C. , Bisignano, C. , Rao, P. , Wool, E. , Johnson, S. C. , Browne, A. J. , Chipeta, M. G. , Fell, F. , Hackett, S. , Haines‐Woodhouse, G. , Hamadani, B. H. K. , Kumaran, E. A. P. , McManigal, B. , & Agarwal, R. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629–655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. World Health Organization . (2019). No time to wait: Securing the future from drug‐resistant infections. [Google Scholar]
- 4. Hu, W. S. , Yao, S.‐M. , Fung, C.‐P. , Hsieh, Y.‐P. , & Liu, C.‐P. (2007). An OXA‐66/OXA‐51‐like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 51, 3844–3852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Trebosc, V. , Gartenmann, S. , Tötzl, M. , Lucchini, V. , Schellhorn, B. , Pieren, M. , Lociuro, S. , Gitzinger, M. , Tigges, M. , Bumann, D. , & Kemmer, C. (2019). Dissecting colistin resistance mechanisms in extensively drug‐resistant Acinetobacter baumannii clinical isolates. mBio, 10, e01083–19. 10.1128/mBio.01083-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Ibrahim, S. , Al‐Saryi, N. , Al‐Kadmy, I. M. S. , & Aziz, S. N. (2021). Multidrug‐resistant Acinetobacter baumannii as an emerging concern in hospitals. Molecular Biology Reports, 48, 6987–6998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Hamidian, M. , & Nigro, S. J. (2019). Emergence, molecular mechanisms and global spread of carbapenem‐resistant Acinetobacter baumannii . Microbial Genomics, 5, e000306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. CDC . (2022). The biggest antibiotic‐resistant threats in the U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/drugresistance/biggest‐threats.html
- 9. Falagas, M. E. , Karveli, E. A. , Kelesidis, I. , & Kelesidis, T. (2007). Community‐acquired Acinetobacter infections. European Journal of Clinical Microbiology & Infectious Diseases, 26, 857–868. [DOI] [PubMed] [Google Scholar]
- 10. Denissen, J. , Reyneke, B. , Waso‐Reyneke, M. , Havenga, B. , Barnard, T. , Khan, S. , & Khan, W. (2022). Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community‐acquired infection and risk to human health. International Journal of Hygiene and Environmental Health, 244, 114006. [DOI] [PubMed] [Google Scholar]
- 11. Antunes, L. C. S. , Visca, P. , & Towner, K. J. (2014). Acinetobacter baumannii: Evolution of a global pathogen. Pathogens and Disease, 71, 292–301. [DOI] [PubMed] [Google Scholar]
- 12. Pagano, M. , Martins, A. F. , & Barth, A. L. (2016). Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii . Brazilian Journal of Microbiology, 47, 785–792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Zarrilli, R. , Pournaras, S. , Giannouli, M. , & Tsakris, A. (2013). Global evolution of multidrug‐resistant Acinetobacter baumannii clonal lineages. International Journal of Antimicrobial Agents, 41, 11–19. [DOI] [PubMed] [Google Scholar]
- 14. Diancourt, L. , Passet, V. , Nemec, A. , Dijkshoorn, L. , & Brisse, S. (2010). The population structure of Acinetobacter baumannii: Expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One, 5, e10034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Mugnier, P. D. , Poirel, L. , Naas, T. , & Nordmann, P. (2010). Worldwide dissemination of the blaOXA‐23 carbapenemase gene of Acinetobacter baumannii . Emerging Infectious Diseases, 16, 35–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Hamidian, M. , Wynn, M. , Holt, K. E. , Pickard, D. , Dougan, G. , & Hall, R. M. (2014). Identification of a marker for two lineages within the GC1 clone of Acinetobacter baumannii . Journal of Antimicrobial Chemotherapy, 69, 557–558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Holt, K. , Kenyon, J. J. , Hamidian, M. , Schultz, M. B. , Pickard, D. J. , Dougan, G. , & Hall, R. (2016). Five decades of genome evolution in the globally distributed, extensively antibiotic‐resistant Acinetobacter baumannii global clone 1. Microbiology Genomics, 2, e000052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Hamidian, M. , & Hall, R. M. (2018). The AbaR antibiotic resistance islands found in Acinetobacter baumannii global clone 1 ‐ Structure, origin and evolution. Drug Resistance Updates, 41, 26–39. [DOI] [PubMed] [Google Scholar]
- 19. Levy‐Blitchtein, S. , Roca, I. , Plasencia‐Rebata, S. , Vicente‐Taboada, W. , Velásquez‐Pomar, J. , Muñoz, L. , Moreno‐Morales, J. , Pons, M. J. , Valle‐Mendoza, J. , & Vila, J. (2018). Emergence and spread of carbapenem‐resistant Acinetobacter baumannii international clones II and III in Lima, Peru. Emerging Microbes & Infections, 7, 119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Gheorghe, I. , Barbu, I. C. , Surleac, M. , Sârbu, I. , Popa, L. I. , Paraschiv, S. , Feng, Y. , Lazăr, V. , Chifiriuc, M. C. , Oţelea, D. , & Zhiyong, Z. (2021). Subtypes, resistance and virulence platforms in extended‐drug resistant Acinetobacter baumannii Romanian isolates. Scientific Reports, 11, 13288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Shelenkov, A. , Petrova, L. , Zamyatin, M. , Mikhaylova, Y. , & Akimkin, V. (2021). Diversity of international high‐risk clones of Acinetobacter baumannii revealed in a Russian multidisciplinary medical center during 2017–2019. Antibiotics, 10, 1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Hamidian, M. , Hawkey, J. , Wick, R. , Holt, K. E. , & Hall, R. M. (2019). Evolution of a clade of Acinetobacter baumannii global clone 1, lineage 1 via acquisition of carbapenem‐ and aminoglycoside‐resistance genes and dispersion of ISAba1 . Microbial Genomics, 5, e000242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Palmieri, M. , D'Andrea, M. M. , Pelegrin, A. C. , Perrot, N. , Mirande, C. , Blanc, B. , Legakis, N. , Goossens, H. , Rossolini, G. M. , & Belkum, A. (2020). Abundance of colistin‐resistant, OXA‐23‐ and ArmA‐producing Acinetobacter baumannii belonging to international clone 2 in Greece. Frontiers in Microbiology, 11, 668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Zhang, X. , Li, F. , Awan, F. , & Jiang, H. (2021). Molecular epidemiology and clone transmission of carbapenem‐resistant Acinetobacter baumannii in ICU rooms. Frontiers in Cellular and Infection Microbiology, 11, 633817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Farrugia, D. N. , Elbourne, L. D. H. , Hassan, K. A. , Eijkelkamp, B. A. , Tetu, S. G. , Brown, M. H. , Shah, B. S. , Peleg, A. Y. , Mabbutt, B. C. , & Paulsen, I. T. (2013). The complete genome and phenome of a community‐acquired Acinetobacter baumannii . PLoS One, 8, e58628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Jia, H. , Sun, Q. , Ruan, Z. , & Xie, X. (2019). Characterization of a small plasmid carrying the carbapenem resistance gene bla OXA‐72 from community‐acquired Acinetobacter baumannii sequence type 880 in China. Infection and Drug Resistance, 12, 1545–1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Zeana, C. , Larson, E. , Sahni, J. , Bayuga, S. J. , & Wu, F. (2003). The epidemiology of multidrug‐resistant Acinetobacter baumannii does the community represent a reservoir? Infection Control & Hospital Epidemiology, 24, 275–279. [DOI] [PubMed] [Google Scholar]
- 28. Eveillard, M. , Kempf, M. , Belmonte, O. , Pailhoriès, H. , & Joly‐Guillou, M.‐L. (2013). Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community‐acquired infections. International Journal of Infectious Diseases, 17, e802–e805. [DOI] [PubMed] [Google Scholar]
- 29. Ramirez, M. S. , Bonomo, R. A. , & Tolmasky, M. E. (2020). Carbapenemases: Transforming Acinetobacter baumannii into a yet more dangerous menace. Biomolecules, 10, 720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Hickman, A. B. , & Dyda, F. (2015). Mechanisms of DNA transposition. Microbiology Spectrum, 3, MDNA3‐0034‐2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Babakhani, S. , & Oloomi, M. (2018). Transposons: The agents of antibiotic resistance in bacteria. Journal of Basic Microbiology, 58, 905–917. [DOI] [PubMed] [Google Scholar]
- 32. Wijers, C. D. M. , Pham, L. , Menon, S. , Boyd, K. L. , Noel, H. R. , Skaar, E. P. , Gaddy, J. A. , Palmer, L. D. , & Noto, M. J. (2021). Identification of two variants of Acinetobacter baumannii 17978 with distinct genotypes and phenotypes. Infection and Immunity, 89, e0045421. 10.1128/IAI.00454-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Whiteway, C. , Valcek, A. , Philippe, C. , Strazisar, M. , De Pooter, T. , Mateus, I. , Breine, A. , & Van der Henst, C. (2022). Scarless excision of an insertion sequence restores capsule production and virulence in Acinetobacter baumannii . ISME Journal, 16, 1473–1477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Partridge, S. R. , Kwong, S. M. , Firth, N. , & Jensen, S. O. (2018). Mobile genetic elements associated with antimicrobial resistance. Clinical Microbiology Reviews, 31, e00088–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Cambray, G. , Guerout, A.‐M. , & Mazel, D. I. (2010). Integrons. Annual Review of Genetics, 44, 141–166. [DOI] [PubMed] [Google Scholar]
- 36. Partridge, S. R. , Tsafnat, G. , Coiera, E. , & Iredell, J. R. (2009). Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiology Reviews, 33, 757–784. [DOI] [PubMed] [Google Scholar]
- 37. Gillings, M. R. (2017). Class 1 integrons as invasive species. Current Opinion in Microbiology, 38, 10–15. [DOI] [PubMed] [Google Scholar]
- 38. Yakout, M. A. , & Ali, G. H. (2020). Multidrug resistance in integron bearing Klebsiella pneumoniae isolated from Alexandria University hospitals. Egyptian Journal of Microbiology, 77, 3897–3902. [DOI] [PubMed] [Google Scholar]
- 39. Singh, T. , Dar, S. A. , Singh, S. , Shekhar, C. , Wani, S. , Akhter, N. , Bashir, N. , Haque, S. , Ahmad, A. , & Das, S. (2021). Integron mediated antimicrobial resistance in diarrheagenic Escherichia coli in children: In vitro and in silico analysis. Microbial Pathogenesis, 150, 104680. [DOI] [PubMed] [Google Scholar]
- 40. Yao, L. , Ding, Y. , Ding, M. , Yan, X. , Zhang, F. , Zhang, Z. , She, J. , Wang, G. , & Zhou, Y. (2021). Characterization of a novel class 1 integron InSW39 and a novel transposon Tn5393k identified in an imipenem‐nonsusceptible Salmonella Typhimurium strain in Sichuan, China. Diagnostic Microbiology and Infectious Disease, 99, 115263. [DOI] [PubMed] [Google Scholar]
- 41. Escudero, J. A. , Loot, C. , Nivina, A. , & Mazel, D. (2015). The integron: Adaptation on demand. Microbiology Spectrum, 3, MDNA3‐0019–2014. [DOI] [PubMed] [Google Scholar]
- 42. Ghaly, T. M. , Geoghegan, J. L. , Tetu, S. G. , & Gillings, M. R. (2020). The peril and promise of integrons: Beyond antibiotic resistance. Trends in Microbiology, 28, 455–464. [DOI] [PubMed] [Google Scholar]
- 43. Toleman, M. A. , Bennett, P. M. , & Walsh, T. R. (2006). ISCR elements: Novel gene‐capturing systems of the 21st century? Microbiology and Molecular Biology Reviews, 70, 296–316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Castillo, F. , Benmohamed, A. , & Szatmari, G. (2017). Xer site specific recombination: Double and single recombinase systems. Frontiers in Microbiology, 8, 453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Balalovski, P. , & Grainge, I. (2020). Mobilization of pdif modules in Acinetobacter: A novel mechanism for antibiotic resistance gene shuffling? Molecular Microbiology, 114, 699–709. [DOI] [PubMed] [Google Scholar]
- 46. Delihas, N. (2008). Small mobile sequences in bacteria display diverse structure/function motifs. Molecular Microbiology, 67, 475–481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Domingues, S. , Nielsen, K. M. , & da Silva, G. J. (2011). The bla IMP‐5‐carrying integron in a clinical Acinetobacter baumannii strain is flanked by miniature inverted‐repeat transposable elements (MITEs). Journal of Antimicrobial Chemotherapy, 66, 2667–2668. [DOI] [PubMed] [Google Scholar]
- 48. Zong, Z. (2014). The complex genetic context of bla PER‐1 flanked by miniature inverted‐repeat transposable elements in Acinetobacter johnsonii . PLoS One, 9, e90046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Helinski, D. R. (2022). A brief history of plasmids. EcoSal Plus, 10.1128/ecosalplus.esp-0028-2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Bañuelos‐Vazquez, L. A. , Torres Tejerizo, G. , & Brom, S. (2017). Regulation of conjugative transfer of plasmids and integrative conjugative elements. Plasmid, 91, 82–89. [DOI] [PubMed] [Google Scholar]
- 51. Sheppard, A. E. , Stoesser, N. , Wilson, D. J. , Sebra, R. , Kasarskis, A. , Anson, L. W. , Giess, A. , Pankhurst, L. J. , Vaughan, A. , Grim, C. J. , Cox, H. L. , Yeh, A. J. , Sifri, C. D. , Walker, A. S , Peto, T. E. , Crook, D. W. , & Mathers, A. J. , the Modernising Medical Microbiology (MMM) Informatics Group . (2016). Nested Russian doll‐like genetic mobility drives rapid dissemination of the carbapenem resistance gene bla KPC . Antimicrobial Agents and Chemotherapy, 60, 3767–3778. 10.1128/AAC.00464-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Garriss, G. , Waldor, M. K. , & Burrus, V. (2009). Mobile antibiotic resistance encoding elements promote their own diversity. PLoS Genetics, 5, e1000775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Cheng, C. , Sun, J. , Zheng, F. , Lu, W. , Yang, Q. , & Rui, Y. (2016). New structures simultaneously harboring class 1 integron and ISCR1‐linked resistance genes in multidrug‐resistant gram‐negative bacteria. BMC Microbiology, 16, 71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Xiong, J. , Déraspe, M. , Iqbal, N. , Ma, J. , Jamieson, F. B. , Wasserscheid, J. , Dewar, K. , Hawkey, P. M. , & Roy, P. H. (2016). Genome and plasmid analysis of bla IMP‐4‐carrying Citrobacter freundii B38. Antimicrobial Agents and Chemotherapy, 60, 6719–6725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Papa‐Ezdra, R. , Cordeiro, N. F. , Di Pilato, V. , Chiarelli, A. , Pallecchi, L. , Garcia‐Fulgueiras, V. , & Vignoli, R. (2021). Description of novel resistance islands harbouring bla CTX‐M‐2 in IncC type 2 plasmids. Journal of Global Antimicrobial Resistance, 26, 37–41. [DOI] [PubMed] [Google Scholar]
- 56. Jones, L. S. , Toleman, M. A. , Weeks, J. L. , Howe, R. A. , Walsh, T. R. , & Kumarasamy, K. K. (2014). Plasmid carriage of bla NDM‐1 in clinical Acinetobacter baumannii isolates from India. Antimicrobial Agents and Chemotherapy, 58, 4211–4213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Benler, S. , Faure, G. , Altae‐Tran, H. , Shmakov, S. , Zhang, F. , & Koonin, E. (2021). Cargo genes of Tn7‐Like transposons comprise an enormous diversity of defense systems, mobile genetic elements, and antibiotic resistance genes. mBio, 12, e0293821. 10.1128/mBio.02938-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Bou, G. , & Martínez‐Beltrán, J. (2000). Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta‐lactamase in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 44, 428–432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Brown, S. , Young, H. K. , & Amyes, S. G. B. (2005). Characterisation of OXA‐51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clinical Microbiology and Infection, 11, 15–23. [DOI] [PubMed] [Google Scholar]
- 60. Hamidian, M. , & Hall, R. M. (2014). Tn6168, a transposon carrying an ISAba1‐activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii . Journal of Antimicrobial Chemotherapy, 69, 77–80. [DOI] [PubMed] [Google Scholar]
- 61. Segal, H. , Nelson, E. C. , & Elisha, B. G. (2004). Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrobial Agents and Chemotherapy, 48, 612–614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Hamidian, M. , & Hall, R. M. (2013). ISAba1 targets a specific position upstream of the intrinsic ampC gene of Acinetobacter baumannii leading to cephalosporin resistance. Journal of Antimicrobial Chemotherapy, 68, 2682–2683. [DOI] [PubMed] [Google Scholar]
- 63. Corvec, S. , Caroff, N. , Espaze, E. , Giraudeau, C. , & Drugeon, H. (2003). AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. Journal of Antimicrobial Chemotherapy, 52, 629–635. [DOI] [PubMed] [Google Scholar]
- 64. Hamidian, M. , Hancock, D. P. , & Hall, R. M. (2013). Horizontal transfer of an ISAba125‐activated ampC gene between Acinetobacter baumannii strains leading to cephalosporin resistance. Journal of Antimicrobial Chemotherapy, 68, 244–245. [DOI] [PubMed] [Google Scholar]
- 65. Figueiredo, S. , Poirel, L. , Croize, J. , Recule, C. , & Nordmann, P. (2009). In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1‐mediated overexpression of the natural bla OXA‐66 oxacillinase gene. Antimicrobial Agents and Chemotherapy, 53, 2657–2659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Turton, J. F. , Ward, M. E , Woodford, N. , Kaufmann, M. E. , Pike, R. , Livermore, D. M. , & Pitt, T. L. (2006). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii . FEMS Microbiology Letters, 258, 72–77. [DOI] [PubMed] [Google Scholar]
- 67. Ruiz, M. , Marti, S. , Fernandez‐Cuenca, F. , Pascual, A. , & Vila, J. (2007). High prevalence of carbapenem‐hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clinical Microbiology and Infection, 13, 1192–1198. [DOI] [PubMed] [Google Scholar]
- 68. Wong, M. H.‐Y. , Chan, B. K.‐W. , Chan, E. W.‐C. , & Chen, S. (2019). Over‐expression of ISAba1‐linked intrinsic and exogenously acquired OXA type carbapenem‐hydrolyzing‐class D‐ß‐lactamase‐encoding genes is key mechanism underlying carbapenem resistance in Acinetobacter baumannii . Frontiers in Microbiology, 10, 2809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Toleman, M. A. , Spencer, J. , Jones, L. , & Walsh, T. R. (2012). bla NDM‐1 is a chimera likely constructed in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 56, 2773–2776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Wu, W. , Feng, Y. , Tang, G. , Qiao, F. , & McNally, A. (2019). NDM metallo‐β‐lactamases and their bacterial producers in health care settings. Clinical Microbiology Reviews, 32, e00115–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Yong, D. , Toleman, M. A. , Giske, C. G. , Cho, H. S. , Sundman, K. , Lee, K. , & Walsh, T. R. (2009). Characterization of a new metallo‐beta‐lactamase gene, bla NDM‐1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial Agents and Chemotherapy, 53, 5046–5054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Partridge, S. R. , & Iredell, J. R. (2012). Genetic contexts of bla NDM‐1 . Antimicrobial Agents and Chemotherapy, 56, 6065–6067; author reply 6071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Poirel, L. , Dortet, L. , Bernabeu, S. , & Nordmann, P. (2011). Genetic features of bla NDM‐1‐positive Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 55, 5403–5407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Poirel, L. , Bonnin, R. A. , & Nordmann, P. (2011). Analysis of the resistome of a multidrug‐resistant NDM‐1‐producing Escherichia coli strain by high‐throughput genome sequencing. Antimicrobial Agents and Chemotherapy, 55, 4224–4229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Poirel, L. , Lagrutta, E. , Taylor, P. , Pham, J. , & Nordmann, P. (2010). Emergence of metallo‐β‐lactamase NDM‐1‐producing multidrug‐resistant Escherichia coli in Australia. Antimicrobial Agents and Chemotherapy, 54, 4914–4916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Poirel, L. , Figueiredo, S. , Cattoir, V. , Carattoli, A. , & Nordmann, P. (2008). Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrobial Agents and Chemotherapy, 52, 1252–1256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Higgins, P. G. , Zander, E. , & Seifert, H. (2013). Identification of a novel insertion sequence element associated with carbapenem resistance and the development of fluoroquinolone resistance in Acinetobacter radioresistens . Journal of Antimicrobial Chemotherapy, 68, 720–722. [DOI] [PubMed] [Google Scholar]
- 78. Wang, T. , Costa, V. , Jenkins, S. G. , Hartman, B. J. , & Westblade, L. F. (2019). Acinetobacter radioresistens infection with bacteremia and pneumonia. IDCases, 15, e00495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Segal, H. , Jacobson, R. K. , Garny, S. , Bamford, C. M. , & Elisha, B. G. (2007). Extended −10 promoter in ISAba1 upstream of bla OXA‐23 from Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 51, 3040–3041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Nigro, S. J. , & Hall, R. M. (2016). Structure and context of Acinetobacter transposons carrying the oxa23 carbapenemase gene. Journal of Antimicrobial Chemotherapy, 71, 1135–1147. [DOI] [PubMed] [Google Scholar]
- 81. Corvec, S. , Poirel, L. , Naas, T. , Drugeon, H. , & Nordmann, P. (2007). Genetics and expression of the carbapenem‐hydrolyzing oxacillinase gene bla OXA‐23 in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 51, 1530–1533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Abouelfetouh, A. , Mattock, J. , Turner, D. , Li, E. , & Evans, B. A. (2022). Diversity of carbapenem‐resistant Acinetobacter baumannii and bacteriophage‐mediated spread of the OXA23 carbapenemase. Microbial Genomics, 8, 000752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Zander, E. , Seifert, H. , & Higgins, P. G. (2014). Insertion sequence IS18 mediates overexpression of bla OXA‐257 in a carbapenem‐resistant Acinetobacter bereziniae isolate. Journal of Antimicrobial Chemotherapy, 69, 270–271. [DOI] [PubMed] [Google Scholar]
- 84. Poirel, L. , & Nordmann, P. (2006). Genetic structures at the origin of acquisition and expression of the carbapenem‐hydrolyzing oxacillinase gene bla OXA‐58 in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 50, 1442–1448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Ravasi, P. , Limansky, A. S. , Rodriguez, R. E. , Viale, A. M. , & Mussi, M. A. (2011). ISAba825, a functional insertion sequence modulating genomic plasticity and bla OXA‐58 expression in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 55, 917–920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Garny, S. (2006). Distribution, frequency and contribution to the expression of antibiotic resistance gene of an IS element in Acinetobacter baumannii. University of Cape Town. [Google Scholar]
- 87. Sun, J.‐R. , Perng, C.‐L. , Chan, M.‐C. , Morita, Y. , Lin, J.‐C. , Su, C.‐M. , Wang, W.‐Y. , Chang, T.‐Y. , & Chiueh, T.‐S. (2012). A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecycline resistance in Acinetobacter baumannii . PLoS One, 7, e49534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Zang, M. , Adams, F. G. , Hassan, K. A. , & Eijkelkamp, B. A. (2021). The impact of omega‐3 fatty acids on the evolution of Acinetobacter baumannii drug resistance. Microbiology Spectrum, 9, e01455–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Arroyo, L. A. , Herrera, C. M. , Fernandez, L. , Hankins, J. V. , Stephen Trent, M. , & Hancock, R. E. W. (2011). The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrobial Agents and Chemotherapy, 55, 3743–3751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Butler, D. A. , Biagi, M. , Tan, X. , Qasmieh, S. , Bulman, Z P. , & Wenzler, E. (2019). Multidrug resistant Acinetobacter baumannii: Resistance by any other name would still be hard to treat. Current Infectious Disease Reports, 21, 46. [DOI] [PubMed] [Google Scholar]
- 91. Palmer, L. D. , Minor, K. E. , Mettlach, J. A. , Rivera, E. S. , Boyd, K. L. , Caprioli, R. M. , Spraggins, J. M. , Dalebroux, Z. D. , & Skaar, E. P. (2020). Modulating isoprenoid biosynthesis increases lipooligosaccharides and restores Acinetobacter baumannii resistance to host and antibiotic stress. Cell Reports, 32, 108129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Durrant, M. G. , Li, M. M. , Siranosian, B. A. , Montgomery, S. B. , & Bhatt, A. S. (2020). A bioinformatic analysis of integrative mobile genetic elements highlights their role in bacterial adaptation. Cell Host & Microbe, 27, 140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Delcour, A. H. (2009). Outer membrane permeability and antibiotic resistance. Biochimica et Biophysica Acta, 1794, 808–816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. Mussi, M. A. , Limansky, A. S. , & Viale, A. M. (2005). Acquisition of resistance to carbapenems in multidrug‐resistant clinical strains of Acinetobacter baumannii: Natural insertional inactivation of a gene encoding a member of a novel family of β‐barrel outer membrane proteins. Antimicrobial Agents and Chemotherapy, 49, 1432–1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Lee, Y. , Kim, C.‐K. , Lee, H. , Jeong, S. H. , Yong, D. , & Lee, K. (2011). A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the bla OXA‐23 gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 55, 361–363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Wright, M. S. , Jacobs, M. R. , Bonomo, R. A. , & Adams, M. D. (2017). Transcriptome remodeling of Acinetobacter baumannii during infection and treatment. mBio, 8, e02193–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Santos‐Lopez, A. , Marshall, C. W. , Scribner, M. R. , Snyder, D. J. , & Cooper, V. S. (2019). Evolutionary pathways to antibiotic resistance are dependent upon environmental structure and bacterial lifestyle. eLife, 8, e47612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Li, X.‐Z. (2016). Antimicrobial resistance in bacteria: An overview of mechanisms and role of drug efflux pumps. In Xian‐Zhi L., Elkins C. A. & Zgurskaya H. I. (Eds.), Efflux‐mediated antimicrobial resistance in bacteria: Mechanisms, regulation and clinical implications. Springer, pp. 131–202. [Google Scholar]
- 99. Gerson, S. , Nowak, J. , Zander, E. , Ertel, J. , Wen, Y. , Krut, O. , Seifert, H. , & Higgins, P. G. (2018). Diversity of mutations in regulatory genes of resistance‐nodulation‐cell division efflux pumps in association with tigecycline resistance in Acinetobacter baumannii . Journal of Antimicrobial Chemotherapy, 73, 1501–1508. [DOI] [PubMed] [Google Scholar]
- 100. Moffatt, J. H. , Harper, M. , Adler, B. , Nation, R. L. , Li, J. , & Boyce, J. D. (2011). Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 55, 3022–3024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Girardello, R. , Visconde, M. , Cayô, R. , Figueiredo, R. C. , Mori, M. A. , Lincopan, N. , & Gales, A. C. (2017). Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates. Diagnostic Microbiology and Infectious Disease, 87, 37–44. [DOI] [PubMed] [Google Scholar]
- 102. Geisinger, E. , Mortman, N. J. , Vargas‐Cuebas, G. , Tai, A. K. , & Isberg, R. R. (2018). A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii . PLoS Pathogens, 14, e1007030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103. Mann, R. , Rafei, R. , Gunawan, C. , Harmer, C. J. , & Hamidian, M. (2022). Variants of Tn6924, a novel Tn7 family transposon carrying the bla NDM metallo‐β‐lactamase and 14 copies of the aphA6 amikacin resistance genes found in Acinetobacter baumannii . Microbiology Spectrum, 10, e0174521. 10.1128/spectrum.01745-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. Adams‐Haduch, J. M. , Paterson, D. L. , Sidjabat, H. E. , Pasculle, A. W. , Potoski, B. A. , Muto, C. A. , Harrison, L. H. , & Doi, Y. (2008). Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrobial Agents and Chemotherapy, 52, 3837–3843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Wang, X. , Zong, Z. , & Lü, X. (2011). Tn2008 is a major vehicle carrying bla OXA‐23 in Acinetobacter baumannii from China. Diagnostic Microbiology and Infectious Disease, 69, 218–222. [DOI] [PubMed] [Google Scholar]
- 106. Zhou, H. , Zhang, T. , Yu, D. , Pi, B. , Yang, Q. , Zhou, J. , Hu, S. , & Yu, Y. (2011). Genomic analysis of the multidrug‐resistant Acinetobacter baumannii strain MDR‐ZJ06 widely spread in China. Antimicrobial Agents and Chemotherapy, 55, 4506–4512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. Mugnier, P. D. , Poirel, L. , & Nordmann, P. (2009). Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii . Journal of Bacteriology, 191, 2414–2418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Nigro, S. , & Hall, R. M. (2015). Distribution of the bla OXA‐23‐containing transposons Tn2006 and Tn2008 in Australian carbapenem‐resistant Acinetobacter baumannii isolates. Journal of Antimicrobial Chemotherapy, 70, 2409–2411. [DOI] [PubMed] [Google Scholar]
- 109. Zong, G. , Zhong, C. , Fu, J. , Zhang, Y. , Zhang, P. , Zhang, W. , Xu, Y. , Cao, G. , & Zhang, R. (2020). The carbapenem resistance gene bla OXA‐23 is disseminated by a conjugative plasmid containing the novel transposon Tn6681 in Acinetobacter johnsonii M19. Antimicrobial Resistance & Infection Control, 9, 182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110. Huang, Z.‐Y. , Li, J. , Shui, J. , Wang, H.‐C. , Hu, Y.‐M. , & Zou, M.‐X. (2019). Co‐existence of bla OXA‐23 and bla VIM in carbapenem‐resistant Acinetobacter baumannii isolates belonging to global complex 2 in a Chinese teaching hospital. Chinese Medical Journal England, 132, 1166–1172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111. Chen, Y. , Gao, J. , Zhang, H. , & Ying, C. (2017). Spread of the bla OXA‐23‐containing Tn2008 in carbapenem‐resistant Acinetobacter baumannii isolates grouped in CC92 from China. Frontiers in Microbiology, 8, 163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112. Wang, Z. , Li, H. , Zhang, J. , & Wang, H. (2021). Co‐occurrence of bla oxa‐23 in the chromosome and plasmid: Increased fitness in carbapenem‐resistant Acinetobacter baumannii . Antibiotics, 10, 1196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Gallagher, L. A. , Ramage, E. , Weiss, E J. , Radey, M. , Hayden, H. S. , Held, K. G. , Huse, H. K. , Zurawski, D. V. , Brittnacher, M. J. , & Manoil, C. (2015). Resources for genetic and genomic analysis of emerging pathogen Acinetobacter baumannii . Journal of Bacteriology, 197, 2027–2035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114. Jacobs, A. C. , Thompson, M. G. , Black, C. C. , Kessler, J. L. , Clark, L. P. , McQueary, C. N. , Gancz, H. Y. , Corey, B. W. , Moon, J. K. , Si, Y. , Owen, M. T. , Hallock, J. D. , Kwak, Y. I. , Summers, A. , Li, C. Z. , Rasko, D. A. , Penwell, W. F. , Honnold, C. L. , Wise, M. C. , & Waterman, P. E. (2014). AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio, 5, e01076–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. Lee, Y.‐T. , Kuo, S.‐C. , Chiang, M.‐C. , Yang, S.‐P. , Chen, C.‐P. , Chen, T.‐L. , & Fung, C.‐P. (2012). Emergence of carbapenem‐resistant non‐baumannii species of Acinetobacter harboring a bla OXA‐51‐like gene that is intrinsic to A. baumannii . Antimicrobial Agents and Chemotherapy, 56, 1124–1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116. Chen, T.‐L. , Lee, Y.‐T. , Kuo, S.‐C. , Hsueh, P.‐R. , Chang, F.‐Y. , Siu, L.‐K. , & Ko, W.‐C. (2010). Emergence and distribution of plasmids bearing the bla OXA‐51‐like gene with an upstream ISAba1 in carbapenem‐resistant Acinetobacter baumannii isolates in Taiwan. Antimicrobial Agents and Chemotherapy, 54, 4575–4581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117. Héritier, C. , Poirel, L. , & Nordmann, P. (2006). Cephalosporinase over‐expression resulting from insertion of ISAba1 in Acinetobacter baumannii . Clinical Microbiology and Infection, 12, 123–130. [DOI] [PubMed] [Google Scholar]
- 118. Pfeifer, Y. , Wilharm, G. , Zander, E. , Wichelhaus, T. A. , Göttig, S. , Hunfeld, K.‐P. , Seifert, H. , Witte, W. , & Higgins, P. G. (2011). Molecular characterization of bla ndm‐1 in an Acinetobacter baumannii strain isolated in Germany in 2007. Journal of Antimicrobial Chemotherapy, 66, 1998–2001. [DOI] [PubMed] [Google Scholar]
- 119. Bonnin, R. A. , Poirel, L. , Naas, T. , Pirs, M. , Seme, K. , Schrenzel, J. , & Nordmann, P. (2012). Dissemination of New Delhi metallo‐β‐lactamase‐1‐producing Acinetobacter baumannii in Europe. Clinical Microbiology and Infection, 18, E362–E365. [DOI] [PubMed] [Google Scholar]
- 120. Krahn, T. , Wibberg, D. , Maus, I. , Winkler, A. , Bontron, S. , Sczyrba, A. , Nordmann, P. , Pühler, A. , Poirel, L. , & Schlüter, A. (2016). Intraspecies transfer of the chromosomal Acinetobacter baumannii bla ndm‐1 carbapenemase gene. Antimicrobial Agents and Chemotherapy, 60, 3032–3040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121. Acman, M. , Wang, R. , Dorp, L. , Shaw, L. P. , Wang, Q. , Luhmann, N. , Yin, Y. , Sun, S. , Chen, H. , Wang, H. , & Balloux, F. (2022). Role of mobile genetic elements in the global dissemination of the carbapenem resistance gene bla NDM . Nature Communications, 13, 1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122. Hamidian, M. , Holt, K. E. , Pickard, D. , Dougan, G. , & Hall, R. M. A. (2014). GC1 Acinetobacter baumannii isolate carrying AbaR3 and the aminoglycoside resistance transposon TnaphA6 in a conjugative plasmid. Journal of Antimicrobial Chemotherapy, 69, 955–958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123. Nigro, S. J. , Post, V. , & Hall, R. M. (2011). Aminoglycoside resistance in multiply antibiotic‐resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals. Journal of Antimicrobial Chemotherapy, 66, 1504–1509. [DOI] [PubMed] [Google Scholar]
- 124. Karah, N. , Dwibedi, C. K. , Sjöström, K. , Edquist, P. , Johansson, A. , Wai, S. N. , & Uhlin, B. E. (2016). Novel aminoglycoside resistance transposons and transposon‐derived circular forms detected in carbapenem‐resistant Acinetobacter baumannii clinical isolates. Antimicrobial Agents and Chemotherapy, 60, 1801–1818. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125. Ou, H.‐Y. , Kuang, S. N. , He, X. , Molgora, B. M. , Ewing, P. J. , Deng, Z. , Osby, M. , Chen, W. , & Howard Xu, H. (2015). Complete genome sequence of hypervirulent and outbreak‐associated Acinetobacter baumannii strain LAC‐4: Epidemiology, resistance genetic determinants and potential virulence factors. Scientific Reports, 5, 8643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126. Post, V. , & Hall, R. M. (2009). AbaR5, a large multiple‐antibiotic resistance region found in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 53, 2667–2671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127. McGann, P. , Courvalin, P. , Snesrud, E. , Clifford, R. , Yoon, E.‐J. , Onmus‐Leone, F. , Ong, A. C. , Kwak, Y. , Grillot‐Courvalin, C. , Lesho, E. , & Waterman, P. (2014). Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure. mBio, 5, e00915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128. Harmer, C. J. , Lebreton, F. , Stam, J. , McGann, P. T. , & Hall, R. M. (2022). Mechanisms of IS26‐mediated amplification of the aphA1 gene leading to tobramycin resistance in an Acinetobacter baumannii isolate. Microbiology Spectrum, 10, e0228722. 10.1128/spectrum.02287-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129. Bertini, A. , Poirel, L. , Bernabeu, S. , Fortini, D. , Villa, L. , Nordmann, P. , & Carattoli, A. (2007). Multicopy bla OXA‐58 gene as a source of high‐level resistance to carbapenems in Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 51, 2324–2328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130. Jones, N. I. , Harmer, C. J. , Hamidian, M. , & Hall, R. M. (2022). Evolution of Acinetobacter baumannii plasmids carrying the oxa58 carbapenemase resistance gene via plasmid fusion, IS26‐mediated events and dif module shuffling. Plasmid, 121, 102628. [DOI] [PubMed] [Google Scholar]
- 131. Andersson, D. I. , Nicoloff, H. , & Hjort, K. (2019). Mechanisms and clinical relevance of bacterial heteroresistance. Nature Reviews Microbiology, 17, 479–496. [DOI] [PubMed] [Google Scholar]
- 132. Cuff, L. E. , Elliott, K. T. , Seaton, S. C. , Ishaq, M. K. , Laniohan, N. S. , Karls, A. C. , & Neidle, E. L. (2012). Analysis of IS1236‐mediated gene amplification events in Acinetobacter baylyi ADP1. Journal of Bacteriology, 194, 4395–4405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133. Martins, N. , Picão, R. C. , Adams‐Sapper, S. , Riley, L. W. , & Moreira, B. M. (2015). Association of class 1 and 2 integrons with multidrug‐resistant Acinetobacter baumannii international clones and Acinetobacter nosocomialis isolates. Antimicrobial Agents and Chemotherapy, 59, 698–701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134. Gombac, F. , Riccio, M. L. , Rossolini, G. M. , Lagatolla, C. , Tonin, E. , Monti‐Bragadin, C. , Lavenia, A. , & Dolzani, L. (2002). Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays. Antimicrobial Agents and Chemotherapy, 46, 3665–3668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135. Chen, F.‐J. , Huang, W.‐C. , Liao, Y.‐C. , Wang, H.‐Y. , Lai, J.‐F. , Kuo, S.‐C. , Lauderdale, T.‐L. , & Sytwu, H.‐K. (2019). Molecular epidemiology of emerging carbapenem resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014. Antimicrobial Agents and Chemotherapy, 63, e02007–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136. Chan, A. P. , Choi, Y. , Clarke, T. H. , Brinkac, L. M. , White, R. C. , Jacobs, M. R. , Bonomo, R. A. , Adams, M. D. , & Fouts, D. E. (2020). AbGRI4, a novel antibiotic resistance island in multiply antibiotic‐resistant Acinetobacter baumannii clinical isolates. Journal of Antimicrobial Chemotherapy, 75, 2760–2768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137. Nigro, S. J. , & Hall, R. M. (2011). GIsul2, a genomic island carrying the sul2 sulphonamide resistance gene and the small mobile element CR2 found in the Enterobacter cloacae subspecies cloacae type strain ATCC 13047 from 1890, Shigella flexneri ATCC 700930 from 1954 and Acinetobacter baumannii ATCC 17978 from 1951. Journal of Antimicrobial Chemotherapy, 66, 2175–2176. [DOI] [PubMed] [Google Scholar]
- 138. Wailan, A. M. , Sidjabat, H. E. , Yam, W. K. , Alikhan, N.‐F. , Petty, N. K. , Sartor, A. L. , Williamson, D. A. , Forde, B. M. , Schembri, M. A. , Beatson, S. A. , Paterson, D. L. , Walsh, T. R. , & Partridge, S. R. (2016). Mechanisms involved in acquisition of bla NDM genes by IncA/C2 and IncFIIY plasmids. Antimicrobial Agents and Chemotherapy, 60, 4082–4088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139. Anderson, S. E. , Chin, C. Y. , Weiss, D. S. , & Rather, P. N. (2020). Copy number of an integron‐encoded antibiotic resistance locus regulates a virulence and opacity switch in Acinetobacter baumannii AB5075. mBio, 11, e02338–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140. Tipton, K. A. , Dimitrova, D. , & Rather, P. N. (2015). Phase‐variable control of multiple phenotypes in Acinetobacter baumannii strain AB5075. Journal of Bacteriology, 197, 2593–2599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141. Chin, C. Y. , Tipton, K. A. , Farokhyfar, M. , Burd, E. M. , Weiss, D. S. , & Rather, P. N. (2018). A high‐frequency phenotypic switch links bacterial virulence and environmental survival in Acinetobacter baumannii . Nature Microbiology, 3, 563–569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142. Ahmad, I. , Karah, N. , Nadeem, A. , Wai, S. N. , & Uhlin, B. E. (2019). Analysis of colony phase variation switch in Acinetobacter baumannii clinical isolates. PLoS One, 14, e0210082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143. Anderson, S. E. , Sherman, E. X. , Weiss, D. S. , & Rather, P. N. (2018). Aminoglycoside heteroresistance in Acinetobacter baumannii AB5075. mSphere, 3, e00271–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144. D'Andrea, M. M. , Giani, T. , D'Arezzo, S. , Capone, A. , Petrosillo, N. , Visca, P. , Luzzaro, F. , & Rossolini, G. M. (2009). Characterization of pABVA01, a plasmid encoding the OXA‐24 carbapenemase from Italian isolates of Acinetobacter baumannii . Antimicrobial Agents and Chemotherapy, 53, 3528–3533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145. Merino, M. , Acosta, J. , Poza, M. , Sanz, F. , Beceiro, A. , Chaves, F. , & Bou, G. (2010). OXA‐24 carbapenemase gene flanked by XerC/XerD‐like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrobial Agents and Chemotherapy, 54, 2724–2727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146. Grosso, F. , Quinteira, S. , Poirel, L. , Novais, Â. , & Peixe, L. (2012). Role of common bla OXA‐24/OXA‐40‐carrying platforms and plasmids in the spread of OXA‐24/OXA‐40 among Acinetobacter species clinical isolates. Antimicrobial Agents and Chemotherapy, 56, 3969–3972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147. Cayô, R. , Merino, M. , Castillo, B. R. , Cano, M. E. , Calvo, J. , Bou, G. , & Martínez‐Martínez, L. (2014). OXA‐207, a novel OXA‐24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain. Antimicrobial Agents and Chemotherapy, 58, 4944–4948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148. Brasiliense, D. M. , Lima, K. V. B. , Pérez‐Chaparro, P. J. , Mamizuka, E. M. , Souza, C. O. , Dutra, L. M. G. , & McCulloch, J. A. (2019). Emergence of carbapenem‐resistant Acinetobacter pittii carrying the bla OXA‐72 gene in the Amazon region, Brazil. Diagnostic Microbiology and Infectious Disease, 93, 82–84. [DOI] [PubMed] [Google Scholar]
- 149. Chagas, T. P. G. , Oliveira, T. R. T. E. , Carvalho‐Assef, A. P. D. , Albano, R. M. , & Asensi, M. D. (2017). Carbapenem‐resistant Acinetobacter pittii strain harboring bla OXA‐72 from Brazil. Diagnostic Microbiology and Infectious Disease, 88, 93–94. [DOI] [PubMed] [Google Scholar]
- 150. Povilonis, J. , Seputiene, V. , Krasauskas, R. , Juskaite, R. , & Miskinyte, M. (2013). Spread of carbapenem‐resistant Acinetobacter baumannii carrying a plasmid with two genes encoding OXA‐72 carbapenemase in Lithuanian hospitals. Journal of Antimicrobial Chemotherapy, 68, 1000–1006. [DOI] [PubMed] [Google Scholar]
- 151. Cameranesi, M. M. , Morán‐Barrio, J. , Limansky, A. S. , Repizo, G. D. , & Viale, A. M. (2018). Site‐specific recombination at XerC/D sites mediates the formation and resolution of plasmid co‐integrates carrying a bla oxa‐58‐ and Tnapha6‐resistance module in Acinetobacter baumannii . Frontiers in Microbiology, 9, 66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152. Blackwell, G. A. , & Hall, R. M. (2017). The tet39 determinant and the msrE‐mphE genes in Acinetobacter plasmids are each part of discrete modules flanked by inversely oriented pdif (XerC‐XerD) sites. Antimicrobial Agents and Chemotherapy, 61, e00780–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153. Lin, D. L. , Traglia, G. M. , Baker, R. , Sherratt, D. J. , Ramirez, M. S. , & Tolmasky, M. E. (2020). Functional analysis of the Acinetobacter baumannii XerC and XerD site‐specific recombinases: Potential role in dissemination of resistance genes. Antibiotics, 9, E405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154. Gillings, M. R. , Labbate, M. , Sajjad, A. , Giguère, N. J. , Holley, M. P. , & Stokes, H. W. (2009). Mobilization of a Tn402‐like class 1 integron with a novel cassette array via flanking miniature inverted‐repeat transposable element‐like structures. Applied and Environmental Microbiology, 75, 6002–6004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155. Mendes, R. E. , Castanheira, M. , Toleman, M. A. , Sader, H. S. , Jones, R. N. , & Walsh, T. R. (2007). Characterization of an integron carrying bla IMP‐1 and a new aminoglycoside resistance gene, aac(6’)‐31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital. Antimicrobial Agents and Chemotherapy, 51, 2611–2614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156. Poirel, L. , Carrër, A. , Pitout, J. D. , & Nordmann, P. (2009). Integron mobilization unit as a source of mobility of antibiotic resistance genes. Antimicrobial Agents and Chemotherapy, 53, 2492–2498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157. Da Silva, G. J. , & Domingues, S. (2016). Insights on the horizontal gene transfer of carbapenemase determinants in the opportunistic pathogen Acinetobacter baumannii . Microorganisms, 4, E29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 158. Brovedan, M. A. , Cameranesi, M. M. , Limansky, A. S. , Morán‐Barrio, J. , Marchiaro, P. , & Repizo, G. D. (2020). What do we know about plasmids carried by members of the Acinetobacter genus? World Journal of Microbiology and Biotechnology, 36, 109. [DOI] [PubMed] [Google Scholar]
- 159. Leungtongkam, U. , Thummeepak, R. , Tasanapak, K. , & Sitthisak, S. (2018). Acquisition and transfer of antibiotic resistance genes in association with conjugative plasmid or class 1 integrons of Acinetobacter baumannii . PLoS One, 13, e0208468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160. Salgado‐Camargo, A. D. , Castro‐Jaimes, S. , Gutierrez‐Rios, R.‐M. , Lozano, L. F. , Altamirano‐Pacheco, L. , Silva‐Sanchez, J. , Pérez‐Oseguera, Á. , & Volkow, P. (2020). Structure and evolution of Acinetobacter baumannii plasmids. Frontiers in Microbiology, 11, 1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 161. Hamidian, M. , Kenyon, J. J. , Holt, K. E. , Pickard, D. , & Hall, R. M. (2014). A conjugative plasmid carrying the carbapenem resistance gene bla OXA‐23 in AbaR4 in an extensively resistant GC1 Acinetobacter baumannii isolate. Journal of Antimicrobial Chemotherapy, 69, 2625–2628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 162. Nigro, S. J. , Holt, K. E. , Pickard, D. , & Hall, R. M. (2015). Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid. Journal of Antimicrobial Chemotherapy, 70, 1259–1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163. Cerezales, M. , Xanthopoulou, K. , Wille, J. , Krut, O. , Seifert, H. , Gallego, L. , & Higgins, P. G. (2020). Mobile genetic elements harboring antibiotic resistance determinants in Acinetobacter baumannii isolates from Bolivia. Frontiers in Microbiology, 11, 919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164. Weber, B. S. , Ly, P. M. , Irwin, J. N. , Pukatzki, S. , & Feldman, M. F. (2015). A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii . Proceedings of the National Academy of Sciences of the United States of America, 112, 9442–9447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165. Di Venanzio, G. , Moon, K. H. , Weber, B. S. , Lopez, J. , Ly, P. M. , Potter, R. F. , Dantas, G. , & Feldman, M. F. (2019). Multidrug‐resistant plasmids repress chromosomally encoded T6SS to enable their dissemination. Proceedings of the National Academy of Sciences of the United States of America, 116, 1378–1383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166. Devaud, M. , Kayser, F. H. , & Bächi, B. (1982). Transposon‐mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrobial Agents and Chemotherapy, 22, 323–329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167. Kloos, J. , Johnsen, P. J. , & Harms, K. (2021). Tn1 transposition in the course of natural transformation enables horizontal antibiotic resistance spread in Acinetobacter baylyi . Microbiology, 167, 001003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168. Valenzuela, J. K. , Thomas, L. , Partridge, S. R. , Reijden, T. , Dijkshoorn, L. , & Iredell, J. (2007). Horizontal gene transfer in a polyclonal outbreak of carbapenem‐resistant Acinetobacter baumannii . Journal of Clinical Microbiology, 45, 453–460. 10.1128/JCM.01971-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169. Alam, M. Z. (2021). Molecular characterization of integrons and their association with antibiotic resistance in Acinetobacter baumannii isolated from hospitals in Jeddah. Applied Biochemistry and Microbiology, 57, S64–S70. [Google Scholar]
